Major enhancement to in vitro testing of human liver-stage malaria

May 9, 2018, University of South Florida

The large green structures are the P. vivax parasites surrounded by human liver cells. Credit: John Adams, PhD, University of South Florida
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver. The liver stage is significant as it precedes the parasite's ability to infect human blood, the point of which symptoms of malaria first appear.

"Almost all of the current strategies are focused the blood-stage of malaria—after the person has already become infected," said lead author John Adams, Ph.D., distinguished professor at the University of South Florida College of Public Health. "But, in order to eradicate this disease, you need to block the cycle of reinfection and the most efficient way to do that is by blocking the parasite from coming into the person. This has not been possible previously because the methods of studying the liver stage have just not been there. Our technique makes that work possible."

In the study published in Nature Communications, researchers used 384-well plates, the standard tool used for analytical lab research, to cultivate primary human , greatly enhancing parasite development rates. This updated in vitro method allows scientists to more quickly screen preclinical drugs and vaccines than current techniques.

"Some of the other methods for researching liver stage malaria are very expensive with large biomaterial requirements," said co-lead author Alison Roth, Ph.D., University of South Florida College of Public Health. "Our method reduces the cost and biomaterials which makes it much more accessible," Roth said. "It's exciting to know that the model we've developed can be easily adapted to other labs and even used in endemic countries."

Dr. Roth says they're now working on a vaccine to prevent the parasite from infecting cells and eventually drugs to kill the parasite once it's entered the .

Explore further: Why some people may not respond to the malaria vaccine

Related Stories

Why some people may not respond to the malaria vaccine

December 20, 2016
Generating protective immunity against the early liver stage of malaria infection is feasible but has been difficult to achieve in regions with high rates of malaria infection. Researchers at the University of Washington ...

Malaria's key to the liver uncovered

July 27, 2015
Scientists uncover a port of liver entry for malaria parasites in a report published in The Journal of Experimental Medicine. If these results hold up in humans, drugs that target this entry protein might help prevent the ...

Recommended for you

AI doctor could boost chance of survival for sepsis patients

October 22, 2018
Scientists have created an artificial intelligence system that could help treat patients with sepsis.

New drug slashes death rates among drug-resistant TB patients: scientists

October 22, 2018
A new treatment for a deadly drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a landmark clinical trial whose results were revealed exclusively to AFP.

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

Scientists in Sweden may have figured out one way acne bacteria defies treatment

October 22, 2018
Researchers in Sweden have discovered how acne-causing bacteria feed off their human hosts. The study, which was performed at KTH Royal Institute of Technology, could make it possible to find effective ways to treat severe ...

A guide to Acute flaccid myelitis (AFM), the rare, polio-like illness making young children sick

October 22, 2018
A fast-acting, polio-like illness has sickened 62 young children, with an average age of 4, in 22 U.S. states so far this fall.

Home-based biofeedback therapy is effective option for tough-to-treat constipation

October 22, 2018
Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.